Potentiation and tolerance of toll-like receptor priming in human endothelial cells

Translational Research

Volumn 180, Issue , 2017, Pages 53-67.e4

  Koch, Stephen R ^a   Lamb, Fred S ^a   Hellman, Judith ^b   Sherwood, Edward R ^a   Stark, Ryan J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 6; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PAM3CSK4; POLYINOSINIC POLYCYTIDYLIC ACID; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING SERINE THREONINE PROTEIN KINASE 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG; AGFG1 PROTEIN, HUMAN; IRF7 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOPORIN; PAM(3)CSK(4) PEPTIDE; RNA BINDING PROTEIN;

ARTICLE; CELLS BY BODY ANATOMY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS PRESENTATION; CROSS TOLERANCE; CYTOKINE RELEASE; DERMAL MICROVASCULAR ENDOTHELIAL CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPOTENTIATION; INFLAMMATION; INNATE IMMUNITY; INTERFERON PRODUCTION; MALE; NEWBORN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; BIOSYNTHESIS; DRUG EFFECTS; ENDOTHELIUM CELL; IMMUNOLOGICAL TOLERANCE; METABOLISM; PHOSPHORYLATION; UPREGULATION;

ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNE TOLERANCE; INTERFERON REGULATORY FACTOR-7; INTERFERONS; INTERLEUKIN-6; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; NUCLEAR PORE COMPLEX PROTEINS; PHOSPHORYLATION; POLY I-C; RNA-BINDING PROTEINS; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 84994067091     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2016.08.001     Document Type: Article

References (52)

1. 1 Danese, S., Dejana, E., Fiocchi, C., Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 178 (2007), 6017–6022.
2. 2 Deutschman, C.S., Tracey, K.J., Sepsis: current dogma and new perspectives. Immunity 40 (2014), 463–475.
3. 3 Takeda, K., Akira, S., Toll-like receptors in innate immunity. Int Immunol 17 (2005), 1–14.
4. 4 Cook, D.N., Pisetsky, D.S., Schwartz, D.A., Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5 (2004), 975–979.
5. 5 Pradeu, T., Cooper, E.L., The danger theory: 20 years later. Front Immunol, 3, 2012, 287.
6. 6 Michelow, I.C., Olsen, K., Lozano, J., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 113 (2004), 701–707.
7. 7 McKenzie, F.E., Case mortality in polymicrobial bloodstream infections. J Clin Epidemiol 59 (2006), 760–761.
8. 8 Rice, T.W., Rubinson, L., Uyeki, T.M., et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 40 (2012), 1487–1498.
9. 9 Murray, J.L., Connell, J.L., Stacy, A., Turner, K.H., Whiteley, M., Mechanisms of synergy in polymicrobial infections. J Microbiol 52 (2014), 188–199.
10. 10 Nakamura, S., Davis, K.M., Weiser, J.N., Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J Clin Invest 121 (2011), 3657–3665.
11. 11 Pammi, M., Zhong, D., Johnson, Y., Revell, P., Versalovic, J., Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study. BMC Infect Dis, 14, 2014, 390.
12. 12 Cohen, T.S., Hilliard, J.J., Jones-Nelson, O., et al. Staphylococcus aureus alpha toxin potentiates opportunistic bacterial lung infections. Sci Transl Med, 8, 2016, 329ra31.
13. 13 Frazier, W.J., Hall, M.W., Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am 55 (2008), 647–668 xi.
14. 14 Wolk, K., Docke, W.D., von Baehr, V., Volk, H.D., Sabat, R., Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96 (2000), 218–223.
15. 15 Leentjens, J., Kox, M., Koch, R.M., et al. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med 186 (2012), 838–845.
16. 16 Bagchi, A., Herrup, E.A., Warren, H.S., et al. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol 178 (2007), 1164–1171.
17. 17 Sato, S., Takeuchi, O., Fujita, T., Tomizawa, H., Takeda, K., Akira, S., A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int Immunol 14 (2002), 783–791.
18. 18 Ariffin, J.K., Sweet, M.J., Differences in the repertoire, regulation and function of toll-like receptors and inflammasome-forming nod-like receptors between human and mouse. Curr Opin Microbiol 16 (2013), 303–310.
19. 19 Stark, R.J., Choi, H., Koch, S.R., Fensterheim, B.A., Lamb, F.S., Sherwood, E.R., Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A. Clin Sci (Lond) 130 (2016), 451–461.
20. 20 Khakpour, S., Wilhelmsen, K., Hellman, J., Vascular endothelial cell toll-like receptor pathways in sepsis. Innate Immun 21 (2015), 827–846.
21. 21 Kagan, J.C., Su, T., Horng, T., Chow, A., Akira, S., Medzhitov, R., TRAM couples endocytosis of toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9 (2008), 361–368.
22. 22 Dib, H., Chafey, P., Clary, G., et al. Proteomes of umbilical vein and microvascular endothelial cells reflect distinct biological properties and influence immune recognition. Proteomics 12 (2012), 2547–2555.
23. 23 Takahashi, N., Duprez, L., Grootjans, S., et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis, 3, 2012, e437.
24. 24 Genin, P., Morin, P., Civas, A., Impairment of interferon-induced IRF-7 gene expression due to inhibition of ISGF3 formation by trichostatin A. J Virol 77 (2003), 7113–7119.
25. 25 Biswas, S.K., Lopez-Collazo, E., Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30 (2009), 475–487.
26. 26 Akira, S., Takeda, K., Kaisho, T., Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 (2001), 675–680.
27. 27 Cusson-Hermance, N., Khurana, S., Lee, T.H., Fitzgerald, K.A., Kelliher, M.A., Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 280 (2005), 36560–36566.
28. 28 Sun, J., Li, N., Oh, K.S., et al. Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use. Sci Signal, 9, 2016, ra3.
29. 29 Akira, S., Takeda, K., Toll-like receptor signalling. Nat Rev Immunol 4 (2004), 499–511.
30. 30 Nahid, M.A., Satoh, M., Chan, E.K., Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J Immunol 186 (2011), 1723–1734.
31. 31 Addis, R., Campesi, I., Fois, M., et al. Human umbilical endothelial cells (HUVECs) have a sex: characterisation of the phenotype of male and female cells. Biol Sex Differ, 5, 2014, 18.
32. 32 Kudo, F.A., Warycha, B., Juran, P.J., et al. Differential responsiveness of early- and late-passage endothelial cells to shear stress. Am J Surg 190 (2005), 763–769.
33. 33 Ezaki, T., Baluk, P., Thurston, G., La Barbara, A., Woo, C., McDonald, D.M., Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am J Pathol 158 (2001), 2043–2055.
34. 34 Wilhelmsen, K., Mesa, K.R., Prakash, A., Xu, F., Hellman, J., Activation of endothelial TLR2 by bacterial lipoprotein upregulates proteins specific for the neutrophil response. Innate Immun 18 (2012), 602–616.
35. 35 Scott, D.W., Vallejo, M.O., Patel, R.P., Heterogenic endothelial responses to inflammation: role for differential N-glycosylation and vascular bed of origin. J Am Heart Assoc, 2, 2013, e000263.
36. 36 Stark, R., Choi, H., Koch, S., Lamb, F., Sherwood, E., Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS. Innate Immun 21 (2015), 565–574.
37. 37 Muzio, M., Bosisio, D., Polentarutti, N., et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164 (2000), 5998–6004.
38. 38 Rehli, M., Of mice and men: species variations of toll-like receptor expression. Trends Immunol 23 (2002), 375–378.
39. 39 Schroder, K., Irvine, K.M., Taylor, M.S., et al. Conservation and divergence in toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc Natl Acad Sci U S A 109 (2012), E944–E953.
40. 40 Lundberg, A.M., Drexler, S.K., Monaco, C., et al. Key differences in TLR3/poly I: C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood 110 (2007), 3245–3252.
41. 41 Reimer, T., Brcic, M., Schweizer, M., Jungi, T.W., poly(I: C) and LPS induce distinct IRF3 and NF-kappaB signaling during type-I IFN and TNF responses in human macrophages. J Leukoc Biol 83 (2008), 1249–1257.
42. 42 Saud, K., Herrera-Molina, R., Von Bernhardi, R., Pro- and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells. Neurotox Res 8 (2005), 277–287.
43. 43 Suet Ting Tan, R., Lin, B., Liu, Q., et al. The synergy in cytokine production through MyD88-TRIF pathways is co-ordinated with ERK phosphorylation in macrophages. Immunol Cell Biol 91 (2013), 377–387.
44. 44 Sweeney, S.E., Targeting interferon regulatory factors to inhibit activation of the type I IFN response: implications for treatment of autoimmune disorders. Cell Immunol 271 (2011), 342–349.
45. 45 Smith, E.J., Marie, I., Prakash, A., Garcia-Sastre, A., Levy, D.E., IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein. J Biol Chem 276 (2001), 8951–8957.
46. 46 Mori, D., Koide, N., Tsolmongyn, B., et al. Poly I: C enhances production of nitric oxide in response to interferon-gamma via upregulation of interferon regulatory factor 7 in vascular endothelial cells. Microvasc Res 98 (2015), 68–73.
47. 47 Kuri, T., Sorensen, A.S., Thomas, S., et al. Influenza A virus-mediated priming enhances cytokine secretion by human dendritic cells infected with Streptococcus pneumoniae. Cell Microbiol 15 (2013), 1385–1400.
48. 48 Han, K.J., Su, X., Xu, L.G., Bin, L.H., Zhang, J., Shu, H.B., Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J Biol Chem 279 (2004), 15652–15661.
49. 49 Ofengeim, D., Yuan, J., Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol 14 (2013), 727–736.
50. 50 Salvi, V., Bosisio, D., Mitola, S., Andreoli, L., Tincani, A., Sozzani, S., Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. Immunobiology 215 (2010), 756–761.
51. 51 Ma, Z., Moore, R., Xu, X., Barber, G.N., DDX24 negatively regulates cytosolic RNA-mediated innate immune signaling. PLoS Pathog, 9, 2013, e1003721.
52. 52 Huye, L.E., Ning, S., Kelliher, M., Pagano, J.S., Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. Mol Cell Biol 27 (2007), 2910–2918.